Stada Arzneimittel AG
Type
Aktiengesellschaft
Traded asFWB: SAZ
IndustryPharmaceuticals
FoundedDresden, 1895
Headquarters
Bad Vilbel
,
Germany
Key people
  • Peter Goldschmidt CEO
  • Günter von Au (Chairman of the supervisory board)
ProductsGeneric and over-the-counter drugs
Revenue€2.33 billion (2018)
Operating income
€378.1 million (2018)
Net income
€306.9 million (2018)
Total assets€3.335 billion (end 2014)
Total equity€903.3 million (end 2014)
Number of employees
10,416 (FTE, average 2018)
Websitewww.stada.com